AlphaMark Advisors »

SPDR S&P Pharmaceuticals shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $285k 6.6k 42.92
2024-09-30 $276k 6.2k 44.34
2024-06-30 $234k 5.9k 39.82

More positions owned by AlphaMark Advisors

iShares S&P 500 Etf (IVV)
Technology SPDR Etf (XLK)
Health Care SPDR (XLV)
SPDR Trust Unit SR Etf (SPY)
Procter & Gamble Company (PG)
Db-x Msci Eafe Currency-hedged (DBEF)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Financial Select Sector SPDR (XLF)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Industrial SPDR (XLI)
Select Sector Spdr Tr Communic etfeqty (XLC)
Janus Detroit Str Tr (JAAA)
Energy Select Sector SPDR (XLE)
Consumer Staples Select Sect. SPDR (XLP)
Regan Floating Rate Mbs (MBSF)

View all positions for AlphaMark Advisors

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals